Petros Pharmaceuticals Current Ratio 2013-2025 | PTPI

Petros Pharmaceuticals current ratio from 2013 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Petros Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-03-31 $0.01B $0.03B 0.53
2024-12-31 $0.01B $0.02B 0.41
2024-09-30 $0.01B $0.01B 0.85
2024-06-30 $0.01B $0.01B 1.40
2024-03-31 $0.02B $0.01B 1.60
2023-12-31 $0.02B $0.01B 1.89
2023-09-30 $0.02B $0.01B 3.02
2023-06-30 $0.01B $0.01B 1.65
2023-03-31 $0.01B $0.01B 2.02
2022-12-31 $0.02B $0.01B 2.08
2022-09-30 $0.02B $0.01B 2.36
2022-06-30 $0.02B $0.01B 3.10
2022-03-31 $0.03B $0.01B 2.61
2021-12-31 $0.03B $0.03B 0.99
2021-09-30 $0.01B $0.03B 0.40
2021-06-30 $0.02B $0.03B 0.47
2021-03-31 $0.02B $0.04B 0.60
2020-12-31 $0.03B $0.04B 0.62
2020-09-30 $0.03B $0.00B 22.40
2020-06-30 $0.03B $0.00B 28.89
2020-03-31 $0.03B $0.00B 93.52
2019-12-31 $0.01B $0.04B 0.29
2019-09-30 $0.02B $0.00B 25.35
2019-06-30 $0.02B $0.00B 25.87
2019-03-31 $0.02B $0.00B 23.11
2018-12-31 $0.03B $0.00B 9.96
2018-09-30 $0.01B $0.00B 6.41
2018-06-30 $0.01B $0.00B 11.89
2018-03-31 $0.02B $0.00B 12.55
2017-12-31 $0.02B $0.00B 10.54
2017-09-30 $0.02B $0.00B 11.44
2017-06-30 $0.02B $0.00B 9.91
2017-03-31 $0.02B $0.00B 12.28
2016-12-31 $0.03B $0.00B 10.97
2016-09-30 $0.01B $0.00B 3.45
2016-06-30 $0.01B $0.00B 7.37
2016-03-31 $0.01B $0.00B 12.16
2015-12-31 $0.01B $0.00B 12.84
2015-09-30 $0.00B $0.00B 1.18
2015-06-30 $0.00B $0.00B 2.43
2015-03-31 $0.01B $0.00B 5.43
2014-12-31 $0.01B $0.00B 6.29
2014-09-30 $0.01B $0.00B 7.98
2014-06-30 $0.01B $0.00B 22.40
2014-03-31 $0.01B $0.00B 49.24
2013-12-31 $0.02B $0.00B 37.46
2013-09-30 $0.02B $0.00B 118.37
2013-06-30 $0.00B 0.00
2013-03-31 $0.00B 0.00
2012-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.001B $0.005B
Petros Pharmaceuticals Inc. is a men's health company. It engages in identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders. Petros Pharmaceuticals Inc., formerly known as Neurotrope Inc., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) JP $81.683B 31.42
Zoetis (ZTS) US $66.251B 24.72
Daiichi Sankyo, - (DSNKY) JP $46.431B 23.80
Takeda Pharmaceutical (TAK) JP $43.274B 8.83
BeOne Medicines - (ONC) KY $32.874B 0.00
Sandoz Group AG (SDZNY) CH $25.885B 0.00
Summit Therapeutics (SMMT) US $19.799B 0.00
Merck (MKKGY) DE $16.472B 12.07
Shionogi (SGIOY) JP $14.326B 14.35
Neurocrine Biosciences (NBIX) US $13.535B 40.46
United Therapeutics (UTHR) US $12.718B 11.01
Orion OYJ (ORINY) FI $11.482B 27.67
IPSEN (IPSEY) FR $10.802B 0.00
Stevanato Group S.p.A (STVN) IT $7.553B 46.19
Grifols, S.A (GRFS) ES $7.460B 0.00
Corcept Therapeutics (CORT) US $7.414B 60.27
Ionis Pharmaceuticals (IONS) US $6.903B 0.00
Madrigal Pharmaceuticals (MDGL) US $6.436B 0.00
Hikma Pharmaceuticals Plc (HKMPF) GB $5.853B 0.00
Ono Pharmaceutical (OPHLF) JP $5.214B 15.86
Soleno Therapeutics (SLNO) US $4.277B 0.00
Hypermarcas (HYPMY) BR $3.066B 20.17
Crinetics Pharmaceuticals (CRNX) US $2.737B 0.00
Catalyst Pharmaceuticals (CPRX) US $2.596B 9.09
AMNEAL PHARMACEUTICALS, INC (AMRX) US $2.529B 13.68
NewAmsterdam Pharma (NAMS) NL $2.518B 0.00
Centessa Pharmaceuticals (CNTA) GB $2.213B 0.00
Ocular Therapeutix (OCUL) US $1.857B 0.00
Endo (NDOI) US $1.763B 0.00
ARS Pharmaceuticals (SPRY) US $1.756B 0.00
BioCryst Pharmaceuticals (BCRX) US $1.720B 0.00
Evotec AG (EVO) DE $1.481B 0.00
Dyne Therapeutics (DYN) US $1.410B 0.00
Guardian Pharmacy Services (GRDN) US $1.296B 0.00
Aurinia Pharmaceuticals Inc (AUPH) CA $1.223B 24.46
Harrow (HROW) US $1.199B 0.00
Ardelyx (ARDX) US $1.038B 0.00
Avadel Pharmaceuticals (AVDL) IE $1.035B 0.00
Collegium Pharmaceutical (COLL) US $0.986B 5.32
Akebia Therapeutics (AKBA) US $0.961B 0.00
Enliven Therapeutics (ELVN) US $0.948B 0.00
Xeris Biopharma Holdings (XERS) US $0.802B 0.00
ProKidney (PROK) US $0.787B 0.00
Cronos Group (CRON) CA $0.771B 0.00
Amylyx Pharmaceuticals (AMLX) US $0.710B 0.00
KalVista Pharmaceuticals (KALV) US $0.691B 0.00
Relay Therapeutics (RLAY) US $0.622B 0.00
Xencor (XNCR) US $0.621B 0.00
Zevra Therapeutics (ZVRA) US $0.601B 0.00
Tourmaline Bio (TRML) US $0.600B 0.00
Organogenesis (ORGO) US $0.591B 0.00
Elite Pharmaceuticals (ELTP) US $0.563B 0.00
Theravance Biopharma (TBPH) US $0.554B 0.00
USANA Health Sciences (USNA) US $0.550B 11.06
Bioventus (BVS) US $0.537B 13.62
Oruka Therapeutics (ORKA) US $0.516B 0.00
Siga Technologies (SIGA) US $0.477B 9.96
Savara (SVRA) US $0.442B 0.00
Aquestive Therapeutics (AQST) US $0.389B 0.00
Rigel Pharmaceuticals (RIGL) US $0.376B 10.15
AleAnna (ANNA) US $0.347B 0.00
Nanobiotix S.A (NBTX) FR $0.315B 0.00
Aldeyra Therapeutics (ALDX) US $0.302B 0.00
Altimmune (ALT) US $0.296B 0.00
Tonix Pharmaceuticals Holding (TNXP) US $0.284B 0.00
Esperion Therapeutics (ESPR) US $0.279B 0.00
Nektar Therapeutics (NKTR) US $0.274B 0.00
Heron Therapeutics (HRTX) US $0.273B 0.00
Nature's Sunshine Products (NATR) US $0.266B 24.42
OmniAb (OABI) US $0.238B 0.00
Larimar Therapeutics (LRMR) US $0.229B 0.00
Galectin Therapeutics (GALT) US $0.228B 0.00
MediWound (MDWD) IL $0.209B 0.00
4D Molecular Therapeutics (FDMT) US $0.204B 0.00
Lyell Immunopharma (LYEL) US $0.184B 0.00
China SXT Pharmaceuticals (SXTC) CN $0.178B 0.00
Journey Medical (DERM) US $0.177B 0.00
Liminatus Pharma (LIMN) US $0.176B 0.00
Profound Medical (PROF) CA $0.167B 0.00
Aclaris Therapeutics (ACRS) US $0.166B 0.00
Lexeo Therapeutics (LXEO) US $0.154B 0.00
Korro Bio (KRRO) US $0.153B 0.00
Avita Medical (RCEL) US $0.142B 0.00
Ironwood Pharmaceuticals (IRWD) US $0.135B 0.00
Protara Therapeutics (TARA) US $0.123B 0.00
Inhibikase Therapeutics (IKT) US $0.123B 0.00
Cardiol Therapeutics (CRDL) CA $0.122B 0.00
Corbus Pharmaceuticals Holdings (CRBP) US $0.113B 0.00
Innate Pharma SA (IPHYF) FR $0.110B 0.00
Cassava Sciences (SAVA) US $0.104B 0.00
Achieve Life Sciences (ACHV) CA $0.093B 0.00
Fractyl Health (GUTS) US $0.089B 0.00
Champions Oncology (CSBR) US $0.088B 20.03
Metagenomi (MGX) US $0.085B 0.00
Vivani Medical (VANI) US $0.085B 0.00
VAXART, INC (VXRT) US $0.084B 0.00
ESSA Pharma (EPIX) CA $0.083B 0.00
Surrozen (SRZN) US $0.080B 0.00
Nutriband (NTRB) US $0.079B 0.00
Arch Biopartners (ACHFF) CA $0.078B 0.00
PMV Pharmaceuticals (PMVP) US $0.074B 0.00
Context Therapeutics (CNTX) US $0.073B 0.00
Avalo Therapeutics (AVTX) US $0.072B 0.00
Pyxis Oncology (PYXS) US $0.071B 0.00
Inotiv (NOTV) US $0.071B 0.00
Wellgistics Health (WGRX) US $0.069B 0.00
Assertio Holdings (ASRT) US $0.067B 0.00
Rafael Holdings (RFL) US $0.065B 0.00
Dominari Holdings (DOMH) US $0.065B 0.00
DURECT (DRRX) US $0.059B 0.00
Allergy Therapeutics (AGYTF) GB $0.059B 0.00
Telomir Pharmaceuticals (TELO) US $0.058B 0.00
Unicycive Therapeutics (UNCY) US $0.056B 0.00
Verrica Pharmaceuticals (VRCA) US $0.055B 0.00
BioNxt Solutions (BNXTF) CA $0.053B 0.00
ElectroCore (ECOR) US $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) US $0.051B 38.22
Century Therapeutics (IPSC) US $0.049B 0.00
NRx Pharmaceuticals (NRXP) US $0.049B 0.00
Jupiter Neurosciences (JUNS) US $0.047B 0.00
Prelude Therapeutics (PRLD) US $0.046B 0.00
Klotho Neurosciences (KLTO) US $0.046B 0.00
Gain Therapeutics (GANX) US $0.045B 0.00
Acrivon Therapeutics (ACRV) US $0.041B 0.00
Mural Oncology (MURA) IE $0.040B 0.00
Enlivex Therapeutics (ENLV) IL $0.036B 0.00
PolyPid (PYPD) IL $0.035B 0.00
Karyopharm Therapeutics (KPTI) US $0.035B 0.00
Iterum Therapeutics (ITRM) IE $0.032B 0.00
FibroGen (FGEN) US $0.028B 0.00
Tempest Therapeutics (TPST) US $0.028B 0.00
Plus Therapeutics (PSTV) US $0.028B 0.00
SCYNEXIS (SCYX) US $0.027B 0.00
Vivos Therapeutics (VVOS) US $0.027B 0.00
Incannex Healthcare (IXHL) AU $0.026B 0.00
Cosmos Health (COSM) US $0.026B 0.00
Scienture Holdings (SCNX) US $0.025B 0.00
Natural Alternatives (NAII) US $0.022B 0.00
Reviva Pharmaceuticals Holdings (RVPH) US $0.022B 0.00
Relmada Therapeutics (RLMD) US $0.021B 0.00
CASI Pharmaceuticals (CASI) CN $0.019B 0.00
Lipocine (LPCN) US $0.018B 0.00
Mannatech (MTEX) US $0.018B 0.00
BioLineRx (BLRX) IL $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) US $0.016B 0.00
Citius Pharmaceuticals (CTXR) US $0.015B 0.00
ProPhase Labs (PRPH) US $0.015B 0.00
Carisma Therapeutics (CARM) US $0.014B 0.00
Ernexa Therapeutics (ERNA) US $0.014B 0.00
Minerva Neurosciences (NERV) US $0.013B 2.33
TherapeuticsMD (TXMD) US $0.013B 0.00
BioVie (BIVI) US $0.012B 0.00
Phio Pharmaceuticals (PHIO) US $0.012B 0.00
Ainos (AIMD) US $0.011B 0.00
TransCode Therapeutics (RNAZ) US $0.009B 0.00
Lyra Therapeutics (LYRA) US $0.009B 0.00
Biomerica (BMRA) US $0.009B 0.00
XTL Biopharmaceuticals (XTLB) IL $0.009B 0.00
Aptorum Group (APM) GB $0.009B 0.00
Addex Therapeutics (ADXN) CH $0.009B 0.00
Mangoceuticals (MGRX) US $0.009B 0.00
Talphera (TLPH) US $0.009B 0.00
Traws Pharma (TRAW) US $0.008B 0.00
Kiora Pharmaceuticals (KPRX) US $0.008B 0.00
NLS Pharmaceutics (NLSP) CH $0.007B 0.00
Nuvilex (PMCB) US $0.007B 0.00
VYNE Therapeutics (VYNE) US $0.006B 0.00
Indaptus Therapeutics (INDP) US $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) US $0.005B 0.00
InMed Pharmaceuticals (INM) CA $0.005B 0.00
Xenetic Biosciences (XBIO) US $0.005B 0.00
Alaunos Therapeutics (TCRT) US $0.005B 0.00
Quoin Pharmaceuticals (QNRX) US $0.005B 0.00
Clearmind Medicine (CMND) CA $0.004B 0.00
Qualigen Therapeutics (QLGN) US $0.004B 0.00
XORTX Therapeutics (XRTX) CA $0.004B 0.00
SHINECO (SISI) CN $0.003B 0.00
Redhill Biopharma (RDHL) IL $0.003B 0.00
SciSparc (SPRC) IL $0.003B 0.00
PainReform (PRFX) IL $0.003B 0.00
Galmed Pharmaceuticals (GLMD) IL $0.003B 0.00
CERo Therapeutics Holdings (CERO) US $0.003B 0.00
Heatwurx (PCSA) US $0.003B 0.00
Aditxt (ADTX) US $0.002B 0.00
Jaguar Animal Health (JAGX) US $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) US $0.002B 0.00
TNF Pharmaceuticals (TNFA) US $0.002B 0.00
Salarius Pharmaceuticals (SLRX) US $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) US $0.002B 0.00
Conduit Pharmaceuticals (CDT) US $0.001B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.000B 0.00
Indivior (INDV) US $0.000B 10.18
4D Pharma (LBPS) GB $0.000B 0.00
MEI Pharma (MEIP) US $0.000B 0.00
Patheon (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals (RVLP) US $0.000B 0.00
Silence Therapeutics (SLN) GB $0.000B 0.00